Boehringer Ingelheim Launches PCV2 Vaccine in Russia

RUSSIA - With the launch of Ingelvac CircoFLEX by Boehringer Ingelheim on the Russian market, pig producers in that country now have access to the world's market leading vaccine against Porcine Circovirus type 2 (PCV2).
calendar icon 1 July 2010
clock icon 2 minute read

The Russian authorities recently granted Ingelvac CircoFLEX market authorization for use in pigs against diseases associated with PCV2. The vaccine is now being launched nationally in a series of meetings held across Russia during June.

Ingelvac CircoFLEX is being launched just as Russia begins to further expand its pig industry, encouraged by support from the Russian Government that aims at reducing or even eliminating the need for pork imports. Today, Russia produces more than two million tons of pork per year.

Ingelvac CircoFLEX is already used successfully in 45 countries in Asia, the European Union, North America, South America, Oceania and Africa.

The single-shot PCV2 vaccine can be conveniently administered to pigs around weaning, providing them with an efficient protection against clinical signs and economic damages due to porcine Circovirus diseases.

Essentially, almost 100 per cent of pig herds are infected with the PCV2 virus. Acute infections with the virus compromise the immunity of the pigs, leading to high mortality rates, an increased frequency of co-infections with other pathogens and a poor growth performance.

Agricultural inventory and production data for Russia are issued by the Federal State Statistics Service (Rosstat) [click here].

Further Reading

- Find out more information on Post-Weaning Multisystemic Wasting Syndrome (PMWS) by clicking here.
© 2000 - 2023 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.